Secukinumab in bio-experienced patients with moderate-to-severe hidradenitis suppurativa from a single center: an observational retrospective study

Int J Dermatol. 2024 Nov 20. doi: 10.1111/ijd.17583. Online ahead of print.

Authors

Thuy M Tran¹, Christeebella O Akpala², Tung S Tran^{3

4}, Mark Denis P Davis³, Christian L Baum³, Afsaneh Alavi³, David A Wetter³, Giang H Nguyen³

Affiliations

¹ Vinmec Times City International Hospital, Hanoi, Vietnam.
² Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
³ Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
⁴ Hanoi Medical University, Hanoi, Vietnam.

PMID: 39564701
DOI: 10.1111/ijd.17583

No abstract available

Keywords: anti‐interleukin 17A; biologics; hidradenitis suppurativa; medical dermatology; real‐world study; secukinumab; treatment response.

Publication types

Letter